Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
Aehr Test Systems reported weaker results for the quarter ended November 28, 2025. Revenue fell to $9.9 million from $13.5 million, a 27% decline, mainly from lower contactor shipments tied to softness in electric vehicle demand. Six‑month revenue dropped 22% to $20.9 million.
Gross margin compressed to 25.7% from 40.1% as lower production, mix shifts, higher assembly and warranty costs, freight, and tariffs weighed on profitability. Aehr posted a quarterly net loss of $3.2 million, or $0.11 per share, versus a $1.0 million loss a year earlier; six‑month net loss widened to $5.3 million or $0.18 per share.
The company continues to invest in development, with research and development expenses up 31% in the quarter, and is seeing growth in package‑level burn‑in systems and AI‑related applications. Aehr strengthened liquidity by selling 384,380 shares via its ATM program for roughly $10 million of gross proceeds, ending the period with $31.0 million in cash, cash equivalents, and restricted cash and no off‑balance‑sheet debt arrangements disclosed.
Aehr Test Systems filed a current report to note that it issued a press release on January 8, 2026 announcing its financial results for the fiscal 2026 second quarter ended November 28, 2025. The company also used the release to communicate a reinstatement of its fiscal 2026 guidance. The press release is furnished as Exhibit 99.1 and is not deemed filed for liability purposes under certain securities laws.
Aehr Test Systems filed a Form S-8 to register 2,500,000 shares of common stock for its 2023 Equity Incentive Plan and 300,000 shares for its Amended and Restated 2006 Employee Stock Purchase Plan.
The additional shares follow stockholder-approved plan amendments on October 20, 2025 at the company’s 2025 Annual Meeting of Stockholders. The filing incorporates prior S-8 registrations by reference and states that sales will occur as awards under the plans are exercised and/or vest.
Aehr Test Systems reported that stockholders approved amendments to two compensation plans at the company’s 2025 annual stockholders’ meeting held on October 20, 2025. The approvals cover the Amendment to the Amended and Restated 2006 Employee Stock Purchase Plan and the Amendment to the 2023 Equity Incentive Plan.
The company states that the terms of these amendments are set forth in the proxy statement dated September 10, 2025, which is incorporated by reference. The full texts of the amendments were filed as exhibits 10.1 and 10.2. This update was disclosed under Item 5.02 of an 8-K.
Aehr Test Systems director reported an open‑market sale of 6,000 shares of common stock on November 5, 2025 at a weighted average price of $25.7262, with individual trades executed between $25.50 and $25.99.
Following the transaction, the reporting person beneficially owned 218,328 shares, held directly. The filing notes that this amount includes shares subject to unvested restricted stock units.
AEHR Test Systems reported an insider transaction on a Form 4. On November 3, 2025, an officer (EVP, PPBI Business) had 203 shares of common stock withheld to cover taxes upon the vesting of restricted stock units, coded F at $25.99 per share. This was a tax withholding event, not a market sale by the insider.
Following the transaction, the insider beneficially owns 77,776 shares. The reported total includes shares subject to unvested restricted stock units.
Aehr Test Systems (AEHR) reported an insider equity transaction by its CTO. On 10/27/2025, 102 shares of common stock were withheld at $25.14 to cover tax obligations upon the vesting of restricted stock units; this was not an open‑market sale by the reporting person.
Following this tax withholding, the reporting person beneficially owned 214,518 shares directly. The reported total includes shares subject to unvested restricted stock units.
Aehr Test Systems executive reported a routine tax-withholding transaction. On 10/27/2025, the VP, Contactor Business Unit had 132 shares withheld at $25.14 per share (code F) to cover taxes upon RSU vesting; this was not an open‑market sale.
Following the transaction, the reporting person beneficially owned 29,228 shares directly and 5,214 shares indirectly through a trust.
Aehr Test Systems (AEHR) President and CEO, also a director, reported a routine Form 4 transaction. On 10/27/2025, 819 shares of common stock were withheld at $25.14 under code “F” to satisfy tax obligations upon RSU vesting; this is not a market sale.
Following the transaction, beneficial ownership stands at 261,095 shares direct and 291,628 shares indirect by trust. The reported amounts include shares subject to unvested restricted stock units and unvested restricted shares.
Aehr Test Systems (AEHR) Chief Operating Officer filed a Form 4 reporting an automatic tax withholding related to RSU vesting. On 10/27/2025, 142 shares of common stock were withheld at $25.14 under transaction code F, which reflects shares withheld to cover taxes and is not a sale by the reporting person. Following the transaction, the officer directly beneficially owned 46,784 shares, which the filing notes include shares subject to unvested RSUs.
FAQ
What is the current stock price of Aehr Test Sys (AEHR)?
What is the market cap of Aehr Test Sys (AEHR)?
